Dynavax Technologies
DVAX
#5481
Rank
ยฃ0.96 B
Marketcap
ยฃ8.24
Share price
0.23%
Change (1 day)
-18.81%
Change (1 year)

Market capitalization of Dynavax Technologies (DVAX)

Market cap: ยฃ0.96 Billion

As of December 2025 Dynavax Technologies has a market cap of ยฃ0.96 Billion. This makes Dynavax Technologies the world's 5481th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Dynavax Technologies from 2004 to 2025

End of year Market Cap

Year Marketcap Change
2025ยฃ0.96 B-28.95%
2024ยฃ1.36 B-3.99%
2023ยฃ1.41 B26.41%
2022ยฃ1.12 B-10.26%
2021ยฃ1.25 B247.56%
2020ยฃ0.35 B-1.67%
2019ยฃ0.36 B-19.26%
2018ยฃ0.45 B-45.95%
2017ยฃ0.83 B579.8%
2016ยฃ0.12 B-80.32%
2015ยฃ0.62 B120.02%
2014ยฃ0.28 B-8.77%
2013ยฃ0.31 B-3.12%
2012ยฃ0.32 B18.99%
2011ยฃ0.27 B13.02%
2010ยฃ0.23 B403.15%
2009ยฃ47.63 M108.52%
2008ยฃ22.84 M-77.67%
2007ยฃ0.10 B-45.05%
2006ยฃ0.18 B222.05%
2005ยฃ57.79 M-41.41%
2004ยฃ98.65 M

End of Day market cap according to different sources

On Dec 4th, 2025 the market cap of Dynavax Technologies was reported to be:

ยฃ0.96 Billion
by Nasdaq info icon info icon
ยฃ0.96 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Agenus
AGEN
ยฃ0.10 B-89.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ20.05 B 1,973.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ187.67 B 19,297.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ113.17 B 11,597.08%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ209.77 B 21,581.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
ยฃ73.07 B 7,452.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
ยฃ111.13 B 11,386.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ24.53 B 2,436.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
ยฃ133.83 B 13,732.79%๐Ÿ‡บ๐Ÿ‡ธ USA